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1. Introduction  
Leptospirosis is a serious spirochete zoonotic disease of increasing worldwide prevalence 
and distribution (Bharti et al., 2003; Levett, 2001). The disease especially occurs in tropical 
areas with high rainfall and severe human cases may cause multi-organ failure leading to 
death. The World Health Organization (WHO) has estimated that approximately 10-100 
cases per 100,000 people are infected annually in tropics (WHO, 2003). Although 
leptospirosis has been recognized for many years, it is considered a re-emerging disease of 
humans in many regions, exemplified by recent outbreaks in Brazil (Romero et al., 2003), 
India (Chaudhry et al., 2002), Malaysia (Sejvar et al., 2003), Nicaragua (Ashford et al., 2000; 
Trevejo et al., 1998), Sri Lanka (Epidemiology Unit-Sri Lanka, 2009a) and Thailand 
(Thaipadungpanit et al., 2007). It also causes substantial domestic livestock losses annually 
(Faine et al., 1999).  
The disease occurs mainly in areas where humans or other animals come into contact with 
the urine of infected animals or a urine-polluted environment. Secondary human-to-human 
transmission occurs rarely (WHO, 2003). In tropics, approximately 10% of hospital 
admissions case attributes to leptospirosis infection, particularly following rains or floods 
(Kenneth et al., 2010). True incidence of leptospirosis is under-estimated due to lack of 
appropriate diagnostic capacity, and case finding and reporting in both human and 
veterinary medicine have been limited and biased (Cachay and Vinetz, 2005).  
The clinical diagnosis of leptospirosis is complicated due to the varied and non-specific 
manifestations of its symptoms which resemble those of other infectious diseases in tropics, 
such as dengue fever or dengue hemorrhagic fever, malaria and scrub typhus. Inadequate 
and poor laboratory facilities tend to hamper the accurate identification of leptospirosis, 
thus the disease remains largely under-diagnosed and therefore under-estimated (WHO, 
2003). 
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At present, 26.5 % of the 6.8 billion (2010) of the world population live in the WHO South-
East Asia (WHO SEA) Region and 57% of the 774 million workforce is engaged in 
agriculture (WHO, 2009a). In the last few decades, tropical diseases continue to have 
crippling effects on the inhabitants especially people who live in poverty. The WHO SEA 
Region possess a high burden of tropical diseases such as lymphatic filariasis, soil 
transmitted helminthiasis, visceral leishamaniasis, trachoma, yaws, schistosomiasis, dengue, 
rabies, leprosy, Japanese encephalitis and leptospirosis, which are reported from one or 
more of the Member States of this region (Table 1) (WHO, 2011). The WHO SEA Region is a 
hotspot for emerging infectious diseases especially zoonoses and vector-borne diseases. 
Continuous population growth, mobility, rapid urbanization, environmental changes, 
deforestation, and climate change are acting as major factors that lead to increase the 
infectious diseases incidence in the region. 
 
Fig. 1. Map of the WHO South-East Asia Region. The WHO South-East Asia (SEA) Region 
has eleven Member States: Bangladesh, Bhutan, Democratic People's Republic (DPR) of 
Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, and Timor-Leste. 
Despite the high prevalence of many infectious diseases in the region, up-to-date 
information is not sufficiently available to make an estimation of the burden of diverse 
diseases and any cross-country comparison difficult. Laboratory diagnosis and surveillance 
are crucial to generate proper epidemiological information on the diseases in a country or a 
region (WHO, 2002). However, most of the Member States are lacking proper diagnostic 
laboratories despite the continuation of endemics of these diseases for many decades.  
The aim of this chapter is to summarize the current situations of epidemiology, surveillance 
and laboratory diagnosis of leptospirosis in the WHO SEA Region. We reviewed the 
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literature for the past two decades published in the PubMed (NLM) database. The 
combination of keywords <Country name> and <Leptospirosis> were used as search 
criteria. Appropriate publications were selected and summarized in subsequent sections. 
Furthermore, we used the Google search engine to locate the documents on leptospirosis of 
the WHO SEA Region. 
 
(Adopted from Communicable Disease Newsletter, World Health Organization Regional Office for 
South-East Asia January 2011 Volume 8 issue 1; and revised accordingly leptospirosis situation in the 
WHO South-East Asia Region, World Health Organization Regional Office for South-East Asia)  
Table 1. Distribution of reported tropical diseases in South-East Asia region. 
2. Epidemiology 
Leptospirosis is an important public health problem in resource-poor countries in tropics. In 
tropical regions, cases are reported year-round but predominantly during the rainy season 
(Sarkar et al., 2002; Trevejo et al., 1998). The increased risk during the rainy season becomes 
higher after flooding that accompanies natural disasters, when the human population may 
be exposed to water contaminated with urine from infected animals. Outbreaks associated 
with flooding and natural disasters have occurred in Nicaragua in 1995 (Trevejo et al., 1998), 
in Brazil in 1996 (Barcellos & Sabroza, 2000), and in India in 2002 (Karande et al., 2002). 
Seasonality of leptospirosis would be related to agricultural cycles.  
It has been shown that people who are engaged in agriculture and animal husbandry have 
high risk of leptospirosis in comparison to other occupations (WHO, 2011a). A case-control 
study in Thailand revealed an increased risk of leptospiral infection among persons that 
performed various agricultural activities in wet fields for > 6 hours/day (Tangkanakul et al., 
2005). In tropical areas such as SEA Region, annual incidence rates ranges from 10–100 per 
100,000 people (WHO, 2003) and the disease is endemic in almost all Member States for 
many decades. Recent outbreaks were reported from Sri Lanka, India and Thailand. 
Epidemiology of leptospirosis in SEA Region mainly depends on various socio-cultural, 
occupational, behavioral and environmental factors. Unfortunately, national incidence data 
is not available other than outbreak reports or research based case series studies in many 
SEA Member States (Table 2). Among the Member States, Bangladesh, Bhutan, DPR of 
Korea, Maldives, Myanmar, Nepal and Timor-Leste has limited or no published 
Bangladesh Bhutan DPR Korea Inida Indonesia Maldives Myanmar Nepal Sri Lanka Thailand Timor-Leste
1 Chikungunya ◆ ◆ ◆ ◆ ◆
2 Dengue ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆
3 Japanese Encephalitis ◆ ◆ ◆ ◆ ◆ ◆
4 Leprosy ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆
5 Leptospirosis ◆ ◆ ◆ ◆ ◆ ◆
6 Lymphatic filariasis ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆
7 Rabies ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆
8 Schistosomiasis ◆
9 Soil Transmitted
helminthaiasis
◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆
10 Trachoma ◆ ◆ ◆
11 Visceral Leishmaniasis ◆ ◆ ◆ ◆
12 Yaws ◆ ◆ ◆
Member country name
Disease Name 
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epidemiological information compared to Thailand, Sri Lanka, India and Indonesia (WHO, 
2008). In SEA region, the most recent large leptospirosis outbreak occurred in Sri Lanka in 
2008, with 7,423 clinically diagnosed leptospirosis cases (Incidence rate 35.7 per 100,000 
people) and 207 deaths reported according to leptospirosis case definition (Epidemiology 
Unit-Sri Lanka, 2009b). Although the number of leptospirosis cases and deaths were 
reduced in 2009 and 2010, Sri Lanka still reported the highest annual leptospirosis cases 
among the SEA Member States (4,980 in 2009 and 4,545 cases in 2010). Based on hospital-
based sentinel surveillance data, nearly half of the cases are aged between 30-49 years and 
80% are male. Two thirds of the patients were exposed to paddy fields and muddy areas 
either accidently or due to the nature of occupation. During the 2008 outbreak, 37% of 1,414 
clinically diagnosed cases were positive for genus specific MAT using the Patoc strain of 
Leptospira biflexa. Agampodi et al (2011) and Koizumi et al (2009) have investigated portions 
of the 2008 outbreak serum samples by MAT using a panel of pathogenic strains. The results 
revealed that serogroups Pyrogenes and Sejroe were predominant in Kegalle and Kandy, 
respectively.  
Leptospirosis is an important public health issue in Thailand. From 1995 to 2000, the disease 
incidence rate increased from 0.3 to 23.7 per 100,000 people, although the incident rate has 
dropped in recent years (2009a). In 2009 Bureau of Epidemiology Department of Disease 
Control, Ministry of Public Health Thailand reported that 5,439 leptospirosis cases and 64 
deaths due to leptospirosis (incidence rate of 8.57 per 100,000 people and fatality rate of 0.1 
per 100,000 people) with the male to female ratio of 4:1. Of the 5,439 cases, 72.9% were aged 
between 25 - 64 years and 72.4% were occupied in agriculture and labor sectors. Most 
infections occur in agricultural workers, primarily rice producers (Bureau of Epidemiology 
Department of Disease Control, 2009).  
In India, outbreaks of leptospirosis have increasingly been reported from the coastline: Gujarat 
(Clerke et al., 2002), Mumbai (Karande et al., 2002), Kerala (Kuriakose et al., 2008), Chennai 
(Ratnam et al., 1993) and Andaman Islands (Sehgal et al., 1995). A 5 year consecutive sero-
epidemiological study conducted in Kerala state has shown that 29.6% inhabitants possessed 
anti-leptospiral antibodies and the prevalent serogroups were Autumnalis, Louisiana, 
Australis, and Grippotyphosa (Kuriakose et al., 2008). In another study conducted by Sehgal 
and colleagues as part of a multi-centric study on disease burden due to leptospirosis (initiated 
by the Indian Council of Medical Research in 2000), 3,682 patients with acute febrile illness, 
from 13 different centers in India, were investigated for the presence of current leptospiral 
infection using the Lepto-dipstick test. Of these patients, 469 (12.7%) were found to possess 
anti-leptospiral IgM. The positivity rate ranged from 3.27% in the central zone to 28.16% in the 
southern zone. Fever, body aches and chills were the common symptoms observed. Urinary 
abnormalities, such as oliguria, yellow discoloration of urine and hematuria were found in 
20%-40% of patients. (Sehgal et al., 2003). 
In Indonesia, human leptospirosis cases were reported first in 1952, when it had been 
known as Canicola fever (Smit et al., 1952). There was a marked increase in human 
leptospirosis cases between 2003 (85 cases) to 2007 (666 cases). The outbreak in 2007, 
approximately 93% of the cases were laboratory confirmed and the case fatality rate was 8% 
(WHO, 2009a). However, a recent outbreak in Bantul regency in Indonesia’s central Java 
region had a 27% case fatality (Netnewspublisher, 2011). Prevalence of rickettsioses and 
leptospirosis was investigated among urban residents in Semarang, revealing that 13 out of 
137 febrile patients were confirmed as leptospirosis (Gasem et al., 2009). 
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Although data on leptospirosis in Bangladesh is limited, LaRocque R. C., et al. (2005) 
reported 18% of dengue-negative febrile patients at two Dhaka hospitals were positive for 
leptospirosis by PCR in a 2000 dengue outbreak. In a serosurvey conducted in rural 
Bangladesh in 1994 revealed high prevalence of anti-leptospiral antibodies among both 
patients with jaundice and healthy controls (Morshed et al., 1994). 
There is no published information on human leptospirosis in Bhutan and Myanmar. 
However, leptospirosis in animal populations has been reported from both countries (WHO, 
2009a). In 2000 Maldives reported their first human leptospirosis case (WHO, 2009a). In 
Nepal, no national surveillance program for leptospirosis exists. However, Myint, K. S., et al 
(2010) detected anti-leptospiral antibodies in military personnel participating in an efficacy 
study of a hepatitis E virus vaccine in Nepal. Among the 1,566 study volunteers, the 
prevalence of leptospirosis was 9% among hepatitis cases and 8% among febrile cases. The 
predominant serogroups were Bratislava, Autumnalis, Icterohaemorrhagiae, and Sejroe. 
Timor-Leste and DPR Korea have no published data about human leptospirosis.  
Considering the urgent necessity of obtaining proper and up-to-date leptospirosis burden 
data to formulate and revise ongoing control and prevention activities, the WHO convened 
an international consultation to assess potential methods to determine a global burden of 
leptospirosis in October 2006. As an outcome of this meeting, the Leptospirosis Burden 
Epidemiology Reference Group (LERG), established in partnership with other international 
organizations, has started conducting global research that provides the necessary data for 
designing an appropriate policy targeted towards decreasing the burden of leptospirosis. 
LERG conducted an informal expert consultation on surveillance, diagnosis and risk 
reduction of leptospirosis in SEA Region, in Chennai, India on 17-18 September 2009. The 
experts recommended necessary measures to improve surveillance, estimation of burden of 
the disease, advocacy, awareness and education, diagnosis and vaccination (WHO, 2009b). 
Although WHO's LERG mainly focuses on human leptospirosis and its burden, future 
models which estimate the burden of the disease should pay attention to animal reservoirs, 
climate change and other environmental factors that may have an effect on particular 
regions of the world (Abela-Ridder et al., 2010)   
3. Surveillance systems 
Disease surveillance is a critical component of the health system in generating essential 
epidemiological information for a cost-effective healthcare delivery (WHO, 2002). Through 
surveillance, incidences and distributions of diseases (e.g., leptospirosis) and the 
implications for effective public health strategies are identified. Although surveillance of 
leptospirosis has been in place in many SEA Member States for decades now, it has yet to be 
adopted and implemented as a monitoring tool to address issues related to control and 
prevention of the disease (WHO, 2002). Surveillance of leptospirosis has been proven to be 
an effective and economical disease control tool in detecting and preventing large outbreaks 
(Jena et al., 2004). The WHO provides standards and guidelines for leptospirosis 
surveillance (WHO, 1999). Only a few SEA Member States adopted these standards (e.g., Sri 
Lanka and Thailand). Most of the Member States are lacking specific government policies 
and legal frameworks to support surveillance and have inadequate laboratory facilities and 
reporting systems. Furthermore, there is poor interaction between human and veterinary 
health sectors for better coordination and collaboration toward surveillance and control of 
leptospirosis (Narain and Bhatia, 2010).  
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Among the WHO SEA Member States, Maldives, Myanmar, Sri Lanka and Thailand include 
leptospirosis as one of the notifiable diseases in the country. In India, although leptospirosis 
is not listed as a target disease in the National Surveillance Program for Communicable 
Diseases (NSPCD) or in the Integrated Disease Surveillance Program (IDSP) under the core 
diseases, it is included in 5 endemic States (Maharashtra, Karnataka, Kerala, Gujarat, Tamil 
Nadu) (Regional Medical Research Centre, 2006). 
Sri Lanka’s national disease reporting system, which is empowered by the quarantine and 
prevention of diseases ordinance enacted in 1897 with subsequent amendments, identifies 
28 notifiable diseases including leptospirosis, and provides the guidelines for their reporting 
to physicians and other healthcare personnel (Figure 2). In 2004, in parallel to the notifiable 
diseases reporting system, the government implemented the hospital-based sentinel site 
 
MOH: Medical Office of Health; RE: Regional Epidemiologist; WER: Weekly Epidemiological Report; 
PHI: Public Health Inspector; H544, H399, H411a : specific forms for reporting process. 
Fig. 2. Flow chart on the reporting system of notifiable diseases in Sri Lanka  
(Source: Sentinel site surveillance guidelines (2010), Epidemiology Unit, Ministry of Health,  
Sri Lanka). 
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surveillance for leptospirosis. The sentinel surveillance seeks to obtain clinical (e.g. signs 
and symptoms), epidemiological (e.g. exposures), laboratory (e.g. infected serogroup) and 
prophylactic treatment (e.g. use of antibiotics) information among those suspected of having 
an infection (Epidemiology Unit-Sri Lanka, 2009a).  
Surveillance of leptospirosis and other 49 diseases is currently (2009) undertaken in 
Thailand by the Bureau of Epidemiology, Department of Disease Control, Ministry of Public 
Health. The disease surveillance data such as morbidity rate, mortality rate, gender, age 
group, occupation, place of treatment and type of patient (for death and cure cases) are 
published weekly and annually through the homepage of Bureau of Epidemiology, 
Thailand (http://www.boe.moph.go.th/). 
Leptospirosis is one of the most economically important diseases in the livestock sector and 
possesses a zoonotic hazard towards the people who are involved in this sector. However, 
leptospirosis is drastically neglected in most of the WHO SEA Member States, although its 
surveillance in rodents and domestic animals is important for developing its appropriate 
control and prevention strategies. It is not a priority disease in the veterinary sector and 
there is no systematic surveillance among livestock in the WHO SEA Region. Furthermore, 
there is no veterinary and medical institutional arrangement to estimate the burden of 
leptospirosis in most of the Member States of the WHO SEA region.  
4. Laboratory diagnosis 
Leptospirosis has diverse clinical manifestations that resemble many other tropical 
infectious diseases such as dengue fever, malaria, and scrub typhus which are prevalent in 
the region. Though a large number of fever of unknown origin are reported to the health 
facilities, investigation for leptospirosis is not carried out partly due to poor knowledge of 
clinical manifestations of the disease or lack of proper laboratory diagnostic facilities. Thus a 
large number of leptospirosis cases are reported without laboratory confirmation which 
directly affects the estimated disease burden in the region. Laboratory diagnosis of 
leptospirosis involves two groups of tests. One group is designed to detect anti-leptospiral 
antibodies, while the other group is to detect leptospires, leptospiral antigens, or leptospiral 
nucleic acid in body fluids or tissues (Levett, 2001). Culture and microscopic agglutination 
test (MAT) are the gold standard methods for its laboratory diagnosis. However, these 
methods are laborious for the routine use. 
The MAT is the most widely used diagnostic serological test. Although MAT detects 
serogroup-specific antibodies, it appeared to be of little value for predicting infecting 
serogroup (serovar) of patients (Levett, 2003; Katz et al., 2003; Smythe et al., 2009). MAT 
requires paired sera for definitive diagnosis of leptospirosis. Seroconvension or at least 
fourfold increase in the titer must be observed between acute and convalescent serum 
samples. Anti-leptospiral antibodies detected by MAT are present for months to years after 
infection. Thus, it is difficult to confirm acute infection from a single serum sample. In 
endemic areas, a high titer of 400 or more in a symptomatic patient is generally accepted as a 
criterion for disease confirmation (Levett, 2001). Furthermore, MAT requires maintenance of 
a panel of Leptospira cultures prevalent in a particular geographical area, and appropriate 
quality control must be employed.  
Several whole Leptospira cell-based rapid screening tests for antibody detection in acute 
infection have been developed, including enzyme linked immunosorbent assay (ELISA), 
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latex agglutination test, lateral flow assay, and IgM dipstick (Bharti et al., 2003; Levett, 2001; 
McBride et al., 2005, Toyokawa et al., 2011). These assays have been used as alternatives to 
MAT but have low sensitivity especially during the acute phase (Smits et al., 2001; Effler et 
al., 2002; Hull-Jackson et al., 2006; McBride et al., 2007). Furthermore, the diagnostic 
accuracies of these techniques are poor in some areas where leptospirosis is endemic 
(Blacksell et al., 2006; Myint et al., 2007).  
PCR is demonstrably useful for early diagnosis of leptospirosis before its antibody production 
has commenced. PCR protocols for detection of leptospiral DNA in clinical materials have 
been developed (Ahmed et al., 2009). Conventional or real time PCR assays targeting a range 
of genes, such as 16SrRNA, 23SrRNA, LipL32, LipL21, RpoB, GyrB, OmpL1, LigA and B, and 
flagellin, have been described (Slack et al., 2006; Stoddard et al., 2009; Reitstetter et al., 2006; 
Kawabata et al., 2001). However, PCR may not be widely applied in resource-poor countries 
due to its high operational cost (Sehgal et al., 2003). Thus, diagnostic methods that not only 
have higher sensitivity and accuracy for early-phase leptospirosis but also are applicable 
widely in resource-poor countries remain to be developed. 
 
*No publication were found from Bhutan, DPR Korea, Madives Myanmar and Timor-Leste for the 
period of January, 2009 – October, 2011. 
Table 2. Leptospinosis in WHO South-East Asian Member States bases on the publucation 
published form 2007 to 2011. 
Inadequate and poor laboratory facilities available in the WHO SEA Region, tend to hamper 
the accurate identification of leptospirosis, thus remaining largely under-diagnosed and 
therefore under-estimated (WHO, 2003). Among the WHO SEA Member States, only India, 
Indonesia, Sri Lanka and Thailand have fully or partially implemented laboratory facilities 
to diagnose leptospirosis (WHO, 2009b). However, those laboratories need to be 
Country*
(reference)
Area
Study
duration
No of study
participants
Diganostic
methods used
Point prevalence Demographics
Rsik
factors
Prevalent
serogroup
India
(Chauhan et
al., 2010)
Sub-Himalayan
state of North
India (i.e.
Himachal
Pradesh)
August 1 -
October 31,
2009
13 leptospirosis
suspected patients
IgM ELISA and
PCR (G1 and G2
primers)
10 were IgM
positive, One
positive by PCR
Male: 77%
Age: ranged
24-78years,
mean 44years
old
Contacted
with
animals or
contaminat
ed water
NA
Sri Lanka
(Agampodi et
al., 2011)
Kandy, Kegalle
and  Matale
districts
August 20
2008 - January
6 2009
Of 746 patients with
acute febrile illness 401
probable cases of
leptospirosis were
examined
ELISA, MAT and
PCR
NA NA NA
Pyrogenes,
Javanica, Sejroe
and Hebdomadis
Indonesia
(Gasem et
al., 2009)
Semaranga in
central Java
Feb 2005 - Feb
2006
137 acute
undeferentiated fever
patients
Lepto Tek Dri Dot
(a commercial
prodcut), MAT  and
IgG ELISA
10% NA NA Bataviae
Thailand
(Wuthiekanu
n et al.,
2007)
9 provinces
located in north,
northeast, central
and southern
regions
March 2003 -
November
2004
700 leptospirosis
suspected patients
MAT and culture
20% were
laboratory
confirmed
leptospirosis
patients
Among
confirmed
cases median
age was 35
years (range
10-68 years).
85% were men.
NA
Autumnalis,
Bataviae,
Pyrogenes,
Javanika,
Hebdomadis,
Grippotyphosa
Bangladesh
(Kendall et
al., 2010)
Kamalapur,
Dhaka
Jan 1 - Dec 31,
2001
878 febrile patients.
Only 584 had paired
sera samples
Sceening by IgM
ELIA. Confirmation
by MAT
8.4% (definite +
probable
infection)
Male 41%
Age: 17.8+-
13.1 years
Sarmin and Mini
Nepal (Myint
et al., 2010)
Army unit
stationed in
Kathmandu
July-August
2001
2000 volunteers from
the Nepalese Army
IgM ELISA and
MAT
9% among clinical
hepatitis cases
11% among non
hepatic febrile
cases
All male, mean
age (+-SD)
25.2+-6.25
NA
Bratislava,
Icterohaemorrhagia
e, Autumnalis and
Sejroe
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strengthened and standardized to produce countrywide services and to perform more 
accurate and specific diagnostic procedures. 
In Sri Lanka, two governmental institutions, namely the Medical Research Institute (MRI), 
the Ministry of Health and the Veterinary Research Institute (VRI), Department of Animal 
Health and Production, have the capacity to diagnose leptospirosis using MAT. However, 
MRI is capable of a limited genus level serological diagnosis using only L. biflexa Patoc I 
strain (Dassanayake et al., 2009). In 2008, 37% of 1,414 suspected leptospirosis human cases 
were serological positive, but no information on infective serogroup was available 
(Epidemiology Unit, Ministry of Health, 2009a). 
In India, the isolation of pathogenic leptospires from human and animal hosts in several 
parts of India has been reported (WHO, 2006). Because there are only limited facilities for 
serotyping in the country, most of the isolates were typed to the serogroup level only 
(Gangadhar et al., 2008). 
Diagnosis of leptospirosis in Indonesia has been performed at the Pasteur Institute located 
in Ho Chi Minh (HCM) City, Vietnam (Laras et al., 2002). In-house developed ELISA, MAT 
and PCR methods are employed in Thailand (Kee et al., 1994; Tangkanakul et al., 2005). In 
Thailand, local institutes collaborate with the Collaborating Center for Reference and 
Research on Leptospirosis, Brisbane, Queensland, Australia (Wuthiekanunet al., 2007). 
5. Conclusion  
Leptospirosis is an emerging zoonotic disease of public health importance in countries of the 
WHO's South-East Asia Region. In some Member States, the disease has been endemic for 
many decades and causes sporadic outbreaks. The disease epidemiology is tightly linked to 
regional climatic factors and major occupational sectors such as agricultural and livestock 
workers. Interventions need to give special attention to at-risk geographic areas with a high 
case fatality rate and to individuals of particular socio-demographic characteristics (e.g., men 
and agricultural workers). Further research needs to be carried out concerning more patho-
physiological information of the disease to prevent leptospirosis deaths that could be 
prevented with proper and timely treatment after an early and accurate diagnosis of the 
disease. However, adequate laboratory tests for early diagnosis are still lacking (Toyokawa 
et al, 2011). Diagnostic methods that not only have higher sensitivity and accuracy for early-
phase leptospirosis but also are applicable widely in resource-poor countries need urgently 
to be developed. The existence of large numbers of reservoir animals and route of disease 
transmission make activities in prevention and control of leptospirosis in WHO SEA Region 
difficult, especially with financial constraints. The quality of data on which the control and 
prevention of leptospirosis in the region is based will hinge upon a periodic assessment of 
the efficacy with which the sentinel surveillance system captures, analyzes and disseminates 
information. Data quality along with accurate results from laboratory investigations will 
determine the true burden of leptospirosis infection in each member country and the region.  
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